{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:57:58Z","timestamp":1791017878146,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbagen.2007.10.002","type":"journal-article","created":{"date-parts":[[2007,10,17]],"date-time":"2007-10-17T11:21:12Z","timestamp":1192620072000},"page":"27-33","source":"Crossref","is-referenced-by-count":13,"title":["Catechol-O-methyltransferase: Effects of the val108met polymorphism on protein turnover in human cells"],"prefix":"10.1016","volume":"1780","author":[{"given":"Anne E.","family":"Doyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Yager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2007.10.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4838(95)00071-2","article-title":"Cloning, expression and structure of catechol-O-methyltransferase","volume":"1251","author":"Lundstrom","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2007.10.002_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0031-6997(24)01423-6","article-title":"Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors","volume":"51","author":"Mannisto","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2007.10.002_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1389200023337586","article-title":"Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis","volume":"3","author":"Zhu","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbagen.2007.10.002_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.758679","article-title":"Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity","volume":"203","author":"Scanlon","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2007.10.002_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/clpt.1990.166","article-title":"Human liver catechol-O-methyltransferase pharmacogenetics","volume":"48","author":"Boudikova","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbagen.2007.10.002_bib6","first-page":"5493","article-title":"An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer","volume":"57","author":"Lavigne","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2007.10.002_bib7","first-page":"2107","article-title":"Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk","volume":"58","author":"Thompson","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2007.10.002_bib8","first-page":"4870","article-title":"Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility","volume":"59","author":"Huang","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2007.10.002_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0304-3835(99)00368-7","article-title":"Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase","volume":"150","author":"Matsui","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2007.10.002_bib10","first-page":"635","article-title":"Polymorphic catechol-O-methyltransferase gene and breast cancer risk","volume":"10","author":"Mitrunen","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbagen.2007.10.002_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-200106000-00001","article-title":"Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer","volume":"11","author":"Yim","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbagen.2007.10.002_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008571-200201000-00009","article-title":"Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk","volume":"12","author":"Mitrunen","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbagen.2007.10.002_bib13","first-page":"453","article-title":"Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women","volume":"25","author":"Tan","year":"2003","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.bbagen.2007.10.002_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tox.2004.06.026","article-title":"Catechol-O-methyltransferase Val 108\/158 Met polymorphism in premenopausal breast cancer patients","volume":"204","author":"Sazci","year":"2004","journal-title":"Toxicology"},{"key":"10.1016\/j.bbagen.2007.10.002_bib15","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.npp.1300542","article-title":"The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes","volume":"29","author":"Bilder","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbagen.2007.10.002_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0304-3940(96)13289-4","article-title":"High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease","volume":"221","author":"Kunugi","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbagen.2007.10.002_bib17","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/mds.10268","article-title":"Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease","volume":"17","author":"Goudreau","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbagen.2007.10.002_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008571-200210000-00003","article-title":"Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation","volume":"12","author":"Goodman","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbagen.2007.10.002_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2004.06.033","article-title":"Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes","volume":"214","author":"Doyle","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbagen.2007.10.002_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.mp.4001386","article-title":"Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes","volume":"9","author":"Shield","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbagen.2007.10.002_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbagen.2007.10.002_bib22","unstructured":"ATCC Cell Biology, Product Description, ATCC, www.atcc.org, 2006."},{"key":"10.1016\/j.bbagen.2007.10.002_bib23","series-title":"Current Protocols in Cell Biology","article-title":"Chapter 7: protein labeling and immunoprecipitation, unit 7.1: metabolic labeling with amino acids","author":"Bonifacino","year":"2001"},{"key":"10.1016\/j.bbagen.2007.10.002_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1210\/mend-1-3-216","article-title":"Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines","volume":"1","author":"Davidson","year":"1987","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbagen.2007.10.002_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:BREA.0000032922.87541.31","article-title":"Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma","volume":"86","author":"Journe","year":"2004","journal-title":"Breast. Cancer Res. Treat."},{"key":"10.1016\/j.bbagen.2007.10.002_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/carcin\/19.2.291","article-title":"Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells","volume":"19","author":"Spink","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbagen.2007.10.002_bib27","first-page":"507","article-title":"Spontaneous conversion to estrogen receptor expression by the human breast epithelial cell line, MCF-10A","volume":"6","author":"Lane","year":"1999","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbagen.2007.10.002_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1075-122X.2004.21410.x","article-title":"Transformation of MCF-10A human breast epithelial cells by zeranol and estradiol-17beta","volume":"10","author":"Liu","year":"2004","journal-title":"Breast J."},{"key":"10.1016\/j.bbagen.2007.10.002_bib29","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/sj.onc.1208661","article-title":"Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells","volume":"24","author":"Lu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagen.2007.10.002_bib30","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1131262","article-title":"Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure","volume":"314","author":"Nackley","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2007.10.002_bib31","series-title":"Methods in Molecular Biology","first-page":"67","article-title":"Determining protein half-lives","volume":"Vol. 284","author":"Zhou","year":"2004"},{"key":"10.1016\/j.bbagen.2007.10.002_bib32","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1126\/science.286.5446.1888","article-title":"Posttranslational quality control: folding, refolding, and degrading proteins","volume":"286","author":"Wickner","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2007.10.002_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbrc.2004.10.040","article-title":"Aggresome formation and pharmacogenetics: sulfotransferase 1A3 as a model system","volume":"325","author":"Wang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2007.10.002_bib34","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","article-title":"Aggresomes: a cellular response to misfolded proteins","volume":"143","author":"Johnston","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbagen.2007.10.002_bib35","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1073\/pnas.0502352102","article-title":"Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2007.10.002_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.59.2.263","article-title":"Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1","volume":"59","author":"Siegel","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbagen.2007.10.002_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2003.09.072","article-title":"Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler\u2013Najjar type II","volume":"310","author":"Ohnishi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416507002346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416507002346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T18:25:15Z","timestamp":1737483915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416507002346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0304416507002346"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2007.10.002","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}